B. Riley Securities Sticks to Their Buy Rating for Harrow Health (HROW)

Tip Ranks
2025.09.23 15:25
portai
I'm PortAI, I can summarize articles.

根據 TipRanks 的數據，Mamtani 是一位分析師，平均回報率為-4.4%，成功率為 33.33%。Mamtani 覆蓋醫療保健行業，關注的股票包括 Altimmune、Agenus 和 Cytokinetics。除了 B. Riley Securities，Harrow Health 還在今天發佈的報告中獲得了 Craig-Hallum 的 Chase Knickerbocker 的買入評級。然而，在 9 月 16 日，TR | OpenAI – 4o 重申了對 Harrow Health（NASDAQ: HROW）的持有評級

根據 TipRanks 的數據，Mamtani 是一位分析師，平均回報率為-4.4%，成功率為 33.33%。Mamtani 覆蓋醫療保健行業，關注的股票包括 Altimmune、Agenus 和 Cytokinetics。

除了 B. Riley Securities，Harrow Health 今天還獲得了 Craig-Hallum 的 Chase Knickerbocker 的買入評級。然而，在 9 月 16 日，TR | OpenAI – 4o 重申了對 Harrow Health（NASDAQ: HROW）的持有評級。

Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.